Hypoglycaemia is a key barrier to achieving euglycaemic control in people who are hospitalized. Inpatient hypoglycaemia has been linked to adverse clinical outcomes, including mortality and longer stay in hospital. A number of studies have applied mathematical tools and statistical models to predict inpatient hypoglycaemia and identify factors that may result in hypoglycaemic events. Several different approaches have been tested to prevent inpatient hypoglycaemia. These can be categorized as human intervention, computerized methods or application of medical devices. In this review we provide an overview of the epidemiology of inpatient hypoglycaemia and its impact on patients and hospitals. We also discuss the existing methodology used to predict inpatient hypoglycaemia and the limited number of trials performed to prevent inpatient hypoglycaemia. The review highlights the urgent need for evidence-based methods to reduce inpatient hypoglycaemia.
Background
Hypoglycaemia, defined as blood glucose level ≤3.9 mmol/l, is an important and common clinical problem in people with diabetes who are hospitalized. The prevalence of inpatient hypoglycaemia in England and Wales from the 2017 National Diabetes Inpatient Audit (NaDIA) report is shown in Fig. 1 . The NaDIA report shows that, although the prevalence of all hypoglycaemic episode types has decreased since 2016, almost one in five people with diabetes still experience an episode of hypoglycaemia during their hospital stay.
One of the commonest causes of inpatient hypoglycaemia is the treatment of hyperglycaemia [4] . The current management of inpatient hyperglycaemia in a non-critical care setting remains poor, with glycaemic outcomes varying widely among different centres [1, 2] despite the availability of clear clinical guidance [3] . A recent meta-analysis showed that intensive glycaemic control (with a target glucose level of 5.6-10.0 mmol/l) in patients receiving non-critical care was associated with a trend towards an increased risk of hypoglycaemia [4] . It is estimated that each person with diabetes or hyperglycaemia who experiences hypoglycaemia does so on two occasions on average during their hospitalization, the majority of these occurring overnight [5] . Poor knowledge of insulin therapy among healthcare providers and unexpected nutritional interruption, coupled with a failure to adjust the patient's insulin therapy, contribute to the prevalence of inpatient hypoglycaemia [6] . Training staff to manage variable rate intravenous insulin infusions ('insulin sliding scales'), as well as to understand the often complex insulin regimens used to optimize glucose control, is an ongoing challenge in many centres because of reduced staffing levels and increased workload [6] . All these factors contribute to the high risk of hypoglycaemia among inpatients.
There is increasing evidence that hypoglycaemia during an inpatient stay is associated with adverse outcomes. Inpatient hypoglycaemia is widely recognized as a poor prognostic marker in terms of morbidity and mortality, increased length of stay [7] and cost to the healthcare system [8] . The psychological consequences to each person with diabetes experiencing inpatient hypoglycaemia have not been systematically evaluated and correlated against behaviour change and risk of longer-term diabetes-related complications.
In the present review, we aim to provide an overview of the epidemiology of inpatient hypoglycaemia and its impact on patients and hospitals. We also discuss the existing methodology used to predict inpatient hypoglycaemia and the limited number of trials that have aimed to prevent inpatient hypoglycaemia. The paper highlights the urgent need for evidence-based methods to reduce inpatient hypoglycaemia.
The databases used for the literature search included Medline, Embase and the Cochrane Library. The search was conducted using the keywords 'diabetes', 'hypoglycaemia', 'hospitalized', 'inpatient', 'insulin', 'impact', 'prediction', 'prevention', 'non-critically ill', 'comorbidity', 'management' and 'glycaemia control'. A total of 4572 papers were identified in the primary search, but only 219 papers were regarded as relevant to the present review. The abstracts and full texts from these articles were reviewed and 49 articles were selected and synthesized into this review (Fig. 2) .
Epidemiology of inpatient hypoglycaemia
For the purposes of the present review, inpatient hypoglycaemia refers to episodes of hypoglycaemia which were experienced during an inpatient stay, and were caused by the treatment of hyperglycaemia or existing diabetes. People who were admitted to the hospital because of hypoglycaemia were beyond the scope of this paper.
The NaDIA surveys the care of people with diabetes admitted to one of over 200 hospitals in England and Wales. Over the last 5 years, data from NaDIA have continued to show a high incidence of hypoglycaemia in people with diabetes during their hospital stay, with 18.4% of inpatients with diabetes experiencing at least one episode of hypoglycaemia during the 1 week prior to the inpatient audit in 2017. Seven percent of inpatients with diabetes experienced severe hypoglycaemia (blood glucose < 3.0 mmol/l) and 1.3% of patients experienced episodes of hypoglycaemia requiring injectable rescue treatment in the seven days prior to the audit (185 inpatients) [9] . According to the 2017 NaDIA report, most people with diabetes who had one or more severe hypoglycaemic episodes had been treated with insulin. A total of 30.4% of people in hospital with Type 1 diabetes experienced hypoglycaemia with a blood glucose level < 3 mmol/l; 13.2% of people with insulin-treated Type 2 diabetes experienced similar blood glucose levels. In contrast, only 2.5% of people with Type 2 diabetes who were not on insulin (but may have been on sulfonylureas) experienced a severe hypoglycaemic episode with blood glucose <3 mmol/l.
The NaDIA reports that the highest proportion of severe hypoglycaemic episodes occur between 05:00 and 08:59 h (27.6% of all severe hypoglycaemic episodes). Previous studies have also shown that hypoglycaemia in hospitalized patients occurs with greater frequency overnight and a large proportion of the events occur as a result of anti-hyperglycaemic therapy, within 2 h of administration of insulin or insulin secretagogues [10] .
In one UK study of 3 361 104 people admitted only to internal medicine wards, 27.4% had a diagnosis of diabetes. Of those, only 5% experienced secondary hypoglycaemia 
What's new?
• We identified 4572 references in the literature on the prediction, prevention and management of inpatient hypoglycaemia, but only 49 papers were directly relevant to the review.
• Whilst several papers show an association between hypoglycaemia and subsequent negative clinical and economic impact, there is no evidence that this impact can be reversed by preventing inpatient hypoglycaemia.
• Several papers have identified multiple predictors of hypoglycaemia through multivariate regression modelling; however, no prospective model has been tested to give an individualized prediction of hypoglycaemia at the point of admission, enabling preventative strategies to be employed.
• Future research should be conducted to identify prospective predictors of inpatient hypoglycaemia with the aim of developing evidence-based tools to prevent hypoglycaemia.
ª 2019 Diabetes UK (hypoglycaemia developed during their inpatient stay); however, a total of 10.2% patients (4754 out of 46 408 patients) with secondary hypoglycaemia died during their hospital stay, compared with 9.5% patients (83 508 out of 879 032 patients) without hypoglycaemia (P <0.05) [11] .
In a large retrospective study looking at the national health system in Spain, a total of 5 447 725 people with diabetes who were discharged between January 1997 and December 2010 were reviewed. The prevalence of hypoglycaemia during the hospital stay (i.e. coded as secondary hypoglycaemia, in other words people who were not admitted with hypoglycaemia) increased from 1.1% in 1997 to a peak of 3.8% in 2007 before decreasing to 3.2% in 2010. The prevalence of primary hypoglycaemia remained stable across the 13 years at approximately 1.5% [12] .
A more detailed UK study looked at 1458 capillary blood glucose tests performed over a 2-week period in all hospital patients. The authors identified 148 episodes of hypoglycaemia, with the mean hypoglycaemia capillary blood glucose being 3.38 (AE0.44) mmol/l. The study also showed that the distribution of hypoglycaemia varied widely by location: 65.8% of the hypoglycaemia events took place on medical wards, 6.8% on surgical wards, and 7.4% in the emergency department. However, immediate treatment changes following the episode of hypoglycaemia were made in only 13.4% of patients, which may account of the high rates of recurrent hypoglycaemia (25%) [13] .
Inpatient hypoglycaemia often occurs as a result of changes in medication. The 2017 NaDIA report showed that almost one-third of inpatients with diabetes had a medication error during their hospital stay (31%), which is likely to be a significant risk factor for hypoglycaemia. Among these medication errors, inappropriate dosage and timing of insulin or insulin secretagogues can directly lead to increased rates of hypoglycaemia. The use of electronic prescriptions may reduce the prescription errors but, in themselves, may not change the incidence of management errors such as not adjusting insulin or other medication after the first episode of hypoglycaemia. A comprehensive electronic prescribing system integrated with a decision-making algorithm to advise clinicians to adjust medication according to blood glucose levels is more likely to reduce the incidence of inpatient hypoglycaemia.
Impact of inpatient hypoglycaemia

Clinical impact
Mortality
Inpatient hypoglycaemia has been implicated in the development of adverse clinical outcomes, including increased mortality [14] . One retrospective study in Spain showed that hypoglycaemia (blood glucose <3.9 mmol/l) in 154 510 people with diabetes during their hospitalization was associated with an increased likelihood of in-hospital mortality [odds ratio (OR) 1.12, 95% CI 1.09-1.15] [12] . Another study, also from Spain, used multivariate/multilinear regression models to demonstrate significant associations between inpatient hypoglycaemia and greater inpatient mortality (OR 1.24, 95% CI 1.20-1.28) and a greater likelihood of readmission (OR 1.20, 95% CI 1.17-1.23) [11] .
In the UK, a study conducted in Birmingham in 2012 retrospectively looked at routinely available electronic data of 6374 admissions from inpatients with diabetes and showed that, compared to the group without hypoglycaemia, the adjusted OR of inpatient mortality was 1.62 (95% CI 1.16-2.27) in the group with blood glucose values of 2.3-3.9 mmol/l; the adjusted OR was 2.05 (95% CI 1.24-3.38) in the group with blood glucose values ≤ 2.2 mmol/l [15] . A more quantitative conclusion was given in a study by Turchin et al. [16] in 2009. After retrospectively analysing 4368 admissions in 2582 patients with diabetes hospitalized in the general wards, they found that the odds of inpatient death rose threefold for every 0.56-mmol/l decrease in the lowest blood glucose value below 3.9 mmol/l during hospitalization (P <0.01) [16] .
Cardiovascular outcomes
In a review paper, Yakubovich and Gerstein summarized the roles of inpatient hypoglycaemia in serious cardiovascular outcomes in diabetes [17] . In the DIGAMI 2 trial, 1253 people with Type 2 diabetes or hyperglycaemia who were hospitalized with suspected acute myocardial infarction were treated with an intravenous infusion of insulin/ glucose in order to achieve normoglycaemia [18] . In the first 24 h of admission 2.2% of people experienced symptomatic glucose levels of <3.0 mmol/l. Although these people were more likely to die from all causes (95% CI 1.2 to 3.3) and from cardiovascular causes (95% CI 1.2 to 3.5), during the 2-year follow-up, this hazard ratio was no longer significant when corrected for baseline characteristics including age, weight and comorbidity.
In two further trials of intensive insulin/glucose/potassium regimes for people with acute myocardial infarction, 0.7% of people with a history of diabetes had hypoglycaemia (≤ 3.8 mmol/l) at the time of admission, and a further 2.0% had at least one hypoglycaemic episode during the first 24 h after admission. People with hypoglycaemia on admission were twice as likely to die as those with normoglycaemia (glucose between 3.9 and 7.0 mmol/l; hazard ratio 2.13, 95% CI 1.01 to 4.49); however, people experiencing hypoglycaemia during their admission did not have increased mortality at 30 days after adjustment for cofounders [19] .
Very few studies have reported the long-term non-fatal cardiovascular outcomes of the occurrence of hypoglycaemia while an inpatient. One report from Iran examined the impact of inpatient hypoglycaemia on the incidence of cardiovascular events during a 24-week study in noncritically ill people with Type 2 diabetes. In that study, hypoglycaemic episodes and major cardiovascular events were recorded. The authors found that 44% of the patients who had experienced hypoglycaemia (blood glucose < 3.9 mmol/l) developed cardiovascular events compared with 16% of those who did not experience any hypoglycaemia (P=0.001). The OR for occurrence of a major cardiovascular event after hypoglycaemia was 6.75 (CI 2.4-18.58) [20] .
Other clinical impact
Other adverse clinical outcomes reported following inpatient hypoglycaemia have included a higher frequency of seizures and falls and a more rapid decline in cognitive dysfunction [21] . A study group in the USA showed that older individuals and those with comorbidities or who were severely ill were more likely to experience the adverse consequences of inpatient hypoglycaemia, including higher risk of mortality and adverse cardiovascular outcomes [22] .
Clinicians and nurses may sometimes consider greater glucose variability as a marker of inadequate glucose control; however, recent studies suggest that hypoglycaemia, as opposed to glucose variability, is a stronger predictor of adverse outcomes such as hospital-acquired infections, acute renal failure, death and longer length of stay, in hospitalized, non-critically ill patients [23, 24] .
The adverse clinical outcomes associated with hypoglycaemia are important and need prevention; however, the existing literature does not show that avoidance of hypoglycaemia would necessarily result in improved outcomes. Nor is there good evidence that reducing the length of time spent in hypoglycaemia would prevent adverse clinical outcomes. Furthermore, there are few studies investigating the personal characteristics which would help define which people are more susceptible to hypoglycaemia and which people experience particular adverse outcomes after hypoglycaemia. Further research is needed to understand the nature of the relationship between inpatient hypoglycaemia and the resultant adverse clinical events. Whether this is associative or causative is not clear and needs to be tested with a clear preventative strategy and measure of longer-term outcomes.
Economic impact
Previous economic analysis of clinical studies has shown that inpatients exposed to hypoglycaemia have a significantly longer mean duration of hospital stay compared with unexposed patients: an estimated 12.04 vs 9.90 days (P<0.001) in the retrospective Spanish study [12] and 10.75 vs 4.73 days in a UK-based study [8] . Evans et al. [8] estimated that there was a 24% increase in the estimated average admission cost per patient for those who experienced a hypoglycaemic event compared to those who did not (P < 0.0001).
Another retrospective study performed by Nirantharakumar et al. [15] in the UK in 2012 analysed 6300 inpatient admissions and showed that length of stay, when compared with those without a recorded hypoglycaemic episode, was Preventing inpatient hypoglycaemia is therefore economically essential for the National Health Service (NHS) as well as vitally important for each individual person with diabetes.
Psychosocial impact
In people with Type 1 or Type 2 diabetes, hypoglycaemia has been found to be associated with a reduction in quality of life, increased fear and anxiety, and reduced productivity [25] . Depression also has been shown to be related to number of hypoglycaemic episodes [26] . The psychosocial impact of hypoglycaemia, however, has only been reported in people with diabetes outside of hospital as there are no specific psychological studies in people who experience inpatient hypoglycaemia. Fear of hypoglycaemia in the inpatient setting may promote compensatory behaviours from caregivers in order to avoid hypoglycaemia, such as ª 2019 Diabetes UK decreased insulin doses or excess carbohydrate intake, resulting in poor glycaemic control. Episodes of hypoglycaemia while a person is an inpatient may reduce that person's trust in the hospital and in the healthcare professionals caring for him/her while in hospital. Table 1 shows a summary of the negative impact of inpatient hypoglycaemia.
Prediction of inpatient hypoglycaemia
A number of studies have applied mathematical tools and statistical models to predict inpatient hypoglycaemia (Table 2) .
Demographic predictors
A recent study from Cardiff used data collected from 142 people with diabetes during their admission to hospital to create a hypoglycaemia risk score based on 10 criteria. They used multivariable regression to show that Type 1 diabetes, insulin-treated Type 2 diabetes, duration of diabetes of >10 years, recurrent hypoglycaemia and hypoglycaemia unawareness were the key drivers in the risk score, with the latter two having a weighting higher than the other factors [27] .
Also in the UK, Stuart et al. [28] developed a prediction model from 9584 admissions of people with diabetes using multivariable logistic regression which showed that the occurrence of inpatient hypoglycaemia could be predicted by a number of factors including ethnicity (black and Asian), age (≥75 years) and type of admission (emergency).
One retrospective study in the USA analysed 294 hypoglycaemic events that occurred in 181 hospitalized patients with Type 1 or 2 diabetes. They showed that age was the major demographic determinant, with elderly people with diabetes having the highest risk of hypoglycaemic events in the hospital [29] . In studies conducted in the USA, Elliott et al. [30] and Schafers et al. [31] found that greater weight was an important variable in hypoglycaemia prediction.
A large study performed in nine French university hospitals looked at 811 people with diabetes in hospital. They showed that history of severe hypoglycaemia and male gender were the main demographic predictive factors for severe hypoglycaemia (blood glucose < 3.0 mmol/l) [32] .
Biomarker predictors
The aforementioned US retrospective study [29] showed that albumin level may be an indicator of the severity of hypoglycaemia, with a lower albumin level predicting a more severe hypoglycaemic event. The studies by Elliott et al. [30] and Schafers et al. [31] found that creatinine Increased length of stay (increased cost on hospital beds) [8, 12] Increased cost on treatment
Increased staff burden
Increased fear and anxiety [25] Reduced quality of life [25] Depression [26] Table 2 Predictors of inpatient hypoglycaemia
Category of predictors Predictors
Demographics Age > 75 years [28, 29] Sex (male) [32] Weight (higher) [30, 31] Ethnicity (Black and Asian) [28] Type of diabetes (Type 1) [27] Duration of diabetes [27] Hypoglycaemia unawareness [27] Drugs Insulin [27, 28, 30, 31] Sulfonylurea [27, 28, 30, 31] Other HbA 1c on admission [33] Albumin level < 35g/l [26, 29] Sodium < 125 mmol/l [26] Estimated GFR < 60 mL min
Creatinine clearance [30, 31] C-reactive protein > 50 mg/l [26] Previous hypoglycaemic episodes [27, 32] Type of admission (emergency) [28] clearance was also a predictive variable for hypoglycaemia. The model developed by Stuart et al. [28] identified estimated GFR, C-reactive protein, sodium and albumin as factors in predicting inpatient hypoglycaemia. In these studies, biochemical factors that were not found to be predictive included hyperkalaemia, elevated neutrophil count, haemoglobin level and anaemia.
Medication predictors
Elliott et al. [30] and Schafers et al. [31] identified several medication variables related to a blood glucose <3.9 mmol/l threshold, including basal, prandial and adjustable scale insulin doses, and sulfonylurea use. Stuart et al. [28] reported that confirmed inpatient hypoglycaemia could be predicted by medication (type of insulin and use of sulfonylureas) [28] .
Comorbidity predictors
An individual's HbA 1c level at admission has also been shown to be a predictor of the number of hypoglycaemic events (<3.9 mmol/l) in people with Type 2 diabetes not admitted to the intensive care unit [33] .
Other potential predictors
Despite the predictors of inpatient hypoglycaemia that have been documented (Table 2) , many other factors related to inpatient hypoglycaemia are not electronically captured (Table 3) during the hospital stay. These include quantity and type of food eaten, amount of exercise performed during the hospital stay and missed meals as a result of procedures, operations or investigations. The food intake of each person varies, often depending on their cognitive state as well as on their underlying reason for admission. Common causes of inpatient hypoglycaemia are carbohydrate-insulin mismatch and inappropriate dosing of glucose-lowering agents. A number of statistical methodologies can be used to mitigate this problem of missing data. A common theme in the risk prediction models is the link between the dose of insulin and sulfonylureas and the frequency of hypoglycaemia. An important clinical question when moving from prediction to prevention is how to 'smartdose' the patient when there is a high risk of developing hypoglycaemia without inducing hyperglycaemia.
Prevention of inpatient hypoglycaemia
Different approaches have been tested to prevent inpatient hypoglycaemia. These can be categorized as human intervention, computerized methods or application of medical devices (Table 4) .
Human approach
In a review paper, researchers highlighted that acute illness, hospital routine and gaps in good-quality care predispose patients to hypoglycaemia [34] . They highlighted that many of these factors could be minimized when approached from a systems-based perspective. This requires the creation of a multidisciplinary team, including nurses, healthcare professionals and researchers, to develop strategies to prevent hypoglycaemic events. These teams would target many factors, such as systematic analysis of blood glucose measurements, policies and protocols, coordination of nutrition and insulin administration, transitions of care, staff and patient education, and communication [34] .
Among the different roles in the hospital setting, the role of ward nurses is vitally important in the detection, treatment and prevention of hypoglycaemia as they are often the first people to be alerted to hypoglycaemia by clinical review of the patient or through the routine bedside monitoring of blood glucose [35] . In one Italian hospital a nurse-managed protocol focusing on carbohydrate intake successfully reduced the incidence of hypoglycaemia in 350 patients with diabetes receiving subcutaneous insulin from 0.34 AE 0.33 hypoglycaemic events/day to 0.19 AE 0.30 hypoglycaemic events/day [36] . The protocol included either giving extra carbohydrate, reducing prandial insulin according to the actual food intake, or giving additional intravenous glucose for patients who undergo prolonged fasting.
Other roles in the multidisciplinary team may also be important. A 4-year intervention study in the USA showed that nursing, dietary and patient education regarding insulin- meal matching could largely prevent hypoglycaemia in the majority of inpatients (>60% of cases) [37] . The study involved a collective effort from nurses, physicians and patients. While nurses were constantly alert and physician orders for anti-hyperglycaemic therapy were frequently revised in high-risk patients to avoid hypoglycaemia, patient education was also key to preventing recurrent or severe hypoglycaemia. Close coordination of care between the patient, physician and all other healthcare providers helped identify the cause of hypoglycaemia and which steps should be taken to prevent further episodes. A large, tertiary acute care hospital in the USA established a 'hypoglycaemia committee'. Its initiative was unique in that every case of severe hypoglycaemia was reviewed by physicians, endocrinologists and diabetes specialists. This multidisciplinary approach led to a a reduction in preventable hypoglycaemic events [38] . Significant resources would be needed to replicate this in the NHS, although the 'NaDIA -Harms' audit has just been launched in the UK to identify all people who have experienced a severe hypoglycaemic event while an inpatient.
The human approach has been demonstrated to be effective in reducing inpatient hypoglycaemia but requires significant investment in both diabetes specialist staff and the development of patient and staff education. A single standardized hypoglycaemia prevention protocol is difficult to apply across different hospitals because of variability in patient characteristics, staff expertise and staffing levels, and local governance structures.
Computerized approach
Through retrospective analysis of inpatient data, a number of mathematical models and computer algorithms have been developed to predict individual risk of developing hypoglycaemia during a hospital stay. Accurate prediction could potentially help prevent hypoglycaemia by increasing staff awareness of high-risk patients, resulting in closer monitoring and amendment in medication doses [39] . A systematic review looked at 14 studies applying various kinds of clinical support systems in the care of inpatients with diabetes in non-critical settings. It showed that these systems, such as a computerized physician order entry system, may have a beneficial effect in inpatient glycaemic control, but needs further confirmation [40] .
Kilpatrick et al. [41] from the USA performed a randomized controlled trial to determine whether their predictive informatics hypoglycaemia risk-alert system, supported by trained nurse responders, would reduce the incidence of severe hypoglycaemia in the hospital. The results showed a significant decrease of 68% in the rate of severe hypoglycaemia in alerted high-risk patients vs non-alerted high-risk patients (3.1% vs 9.7%; P=0.012) . This was achieved through nurses or physicians changing orders in 40.7% of the alerted high-risk patients. Orders were changed in only 20.5% of the non-alerted high-risk patients after an initial blood glucose of < 5 mmol/l had occurred. A change in orders referred to modification consistent with lowering the risk of hypoglycaemia, which involved either discontinuing an oral antidiabetic agent, lowering the dose of insulin, or the addition of dextrose-containing fluids. The most common change in orders was a reduction in the total dose of insulin.
In a study from Austria, Spat et al. [42] reported on results from their clinical feasibility study testing the prototype of a mobile, tablet-based client-server system for computerized decision and workflow support and demonstrated the system's positive impact on hypoglycaemia prevention. In this study, 30 inpatients with Type 2 diabetes on a basal-bolus regime participated in the trial and only 1.3% of the total blood glucose measurements were <3.9 mmol/l. The system, which included a computerized decision tool for changing the doses of insulin as well as improving the workflow for decision-making, was able to support healthcare professionals deliver a basal-bolus insulin regimen safely.
The computerized approaches to reducing hypoglycaemia are easier to deliver consistently across large hospitals compared to the human approach. They also require less investment in training and education; however, the predictive accuracy of the models is limited as underlying betweenpatient variability is not taken into account. Increasing the amount of clinical data which could be entered into these algorithms, including demographic features, vital signs, medicine administration information and detailed description about their hypoglycaemia episodes, may enable the development of more reliable and personalized hypoglycaemia-prevention algorithms. These algorithms will not only need to reduce hypoglycaemia, but also avoid a resultant increase in hyperglycaemia.
Medical device approach
Different medical devices have been used in inpatient settings for the management of glycaemic levels in people with diabetes. Apart from the commonly used finger-prick capillary blood glucose testing devices, different real-time continuous glucose monitors, insulin pumps, and closed-loop insulin delivery systems (or 'artificial pancreas') have been extensively researched in the past decade and have been tested in inpatients with diabetes to maintain euglycaemia and to prevent hypoglycaemic episodes.
Continuous glucose monitoring and insulin pumps
Continuous glucose monitoring (CGM) uses a medical device involving insertion of a glucose sensor in the subcutaneous tissue of users. The sensor enables real-time glucose level readings from every 1 to 15 min. An insulin pump is a medical device that continuously titrates insulin, often subcutaneously, into users through an insulin infusion set. The 24-h infusion rate of insulin can be pre-set in the pump by healthcare professionals or users themselves for optimal control of glycaemic levels. A pilot study in the USA assessed the feasibility of using a real-time CGM to discontinue subcutaneous insulin pump therapy when hypoglycaemia was predicted in people with Type 1 diabetes under controlled conditions in a clinical research facility. Using a linear prediction algorithm with a 4.4-mmol/l threshold and a 45-min prediction horizon, hypoglycaemia was prevented 80% of the time [43] . Another research group from the same country developed subjectspecific hypoglycaemia prediction models using time-series analysis on CGM data which have been validated against real patient datasets [44] . Neither study was performed in a traditional inpatient setting.
Cameron et al. [45] developed a predictive hypoglycaemia detection algorithm using CGM data with explicit certainty measures to enable early corrective action. The algorithm used multiple statistical linear predictions with regression windows between 5 and 75 min and prediction horizons of 0 to 20 min. The algorithm has been tested against a real inpatient dataset and demonstrated its effectiveness in providing alarms for early corrective actions.
Spanakis et al. [46] used CGM in general medicine in people with insulin-treated Type 2 diabetes and the results were transmitted to a central nursing station monitoring system. An alarm system was set up at glucose <4.7 mmol/l. The system successfully prevented any CGM value < 3 mmol/ l in five studied inpatients.
Closed-loop insulin delivery
A closed-loop insulin delivery system, or artificial pancreas, is a medical device comprising a CGM device, an insulin pump and a control algorithm that is able to instruct optimal rates of real-time insulin infusion from the pump, using blood glucose measurement data collected from the CGM device. The control algorithm is developed to maintain euglycaemia with a predefined glucose target level or target range.
Closed-loop control of blood glucose levels in people with Type 1 diabetes in an inpatient setting has been demonstrated to be able to increase the time of glucose levels in the target range and to significantly reduce time in hypoglycaemia [47] .
Closed-loop insulin delivery without meal-time boluses has also been demonstrated to be safe and effective in insulin-treated adults with Type 2 diabetes in the inpatient setting, with an increase of 20% time in the target glucose range. However, the system was not designed to reduce hypoglycaemia in the inpatient population and so similar time was spent in the hypoglycaemic range in people using the closed-loop insulin delivery vs those who were not [48] [49] [50] .
Closed-loop insulin delivery has been demonstrated to be safe and effective but costly to use in the inpatient setting. A step of pre-selection patients who would benefit the most from receiving such treatment would be necessary.
Conclusion
Hypoglycaemia is a common barrier to achieving euglycaemia in the inpatient setting and is associated with significant adverse clinical outcomes for both the person with diabetes and the healthcare system. Hypoglycaemia is important to predict, but existing prediction methods are often limited by prediction accuracy, with receiver-operating curve analysis showing an area under the curve of 0.73 [28] . In other studies, the failure rate to predict the hypoglycaemic events in the original analysis was as high as 40% [28] . These suggest that a predictive equation is only one tool among many that will need to be developed to protect people with diabetes from hypoglycaemia in hospital.
Furthermore, any prediction models and preventative strategies would need to be tested in a range of clinical settings to show that the subsequent reduction in hypoglycaemia and improvement in the clinical outcomes could be generalized between settings. It is also important that prevention of hypoglycaemia does not come at the expense of an increase in hyperglycaemia.
Technology can be helpful in reducing the time spent in hypoglycaemia during an inpatient stay, but it is unlikely to be the only factor in reducing inpatient hypoglycaemia. It is of paramount importance to continue to educate junior doctors and support nursing staff to reduce prescribing and glucose management errors. Doctors and nurses should be aware of the consequences of hypoglycaemia while treating hyperglycaemia.
With large amounts of clinical data available and increasing awareness of the tools of big data analysis, more hypoglycaemia prediction models with greater accuracy can be created and tested. Future research should continue to focus on the development of novel computerized drugdelivery algorithms and medical devices for the prevention of inpatient hypoglycaemia. Well-designed studies should evaluate the long-term clinical outcomes, economic benefit and change in psychological well-being when trialling preventative strategies. 
